NCT04221620

Brief Summary

EEG Neurofeedback is a noninvasive way that allows the central nervous system to self regulate and the frontal cortex to be accessed through quieting of the limbic system at the subcortical level. Currently there is limited research in regards to the implications of EEG Neurofeedback, however, the investigators of this study have been using EEG Neurofeedback as a passive modality in the treatment of various pediatric clients with a variety of diagnoses and disorders. The purpose of this study is to determine whether or not EEG neurofeedback is effective in improving executive functioning skills in pediatric, school aged children as a modality in traditional occupational therapy services. The investigators hypothesize that EEG neurofeedback will assist with improved sensory gating abilities, therefore allowing for higher levels of cognition and awareness due to increased opportunities for the brain to regulate itself.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2019

Completed
20 days until next milestone

Study Start

First participant enrolled

January 1, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 9, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2021

Completed
Last Updated

January 9, 2020

Status Verified

January 1, 2020

Enrollment Period

11 months

First QC Date

December 12, 2019

Last Update Submit

January 6, 2020

Conditions

Keywords

EEG neurofeedbackoccupational therapy

Outcome Measures

Primary Outcomes (1)

  • Executive functioning improvements

    Executive functioning improvements as indicated by improved scores on the Behavior Rating Inventory of Executive Functioning second edition, or BRIEF-2, at the end of 20 sessions when EEG neurofeedback was utilized. The BRIEF-2 is considered the gold standard for testing executive functioning and has over 1000 peer reviewed articles. It utilizes three different scoring sub-sections- typical, potentially clinically elevated. or clinically elevated. Participants in this study must score within the potentially clinically elevated or clinically elevated levels to qualify. Ideally, moving up one section to typical range or potentially elevated range would demonstrate positive study results.

    minimum 20 weeks, up to 8 months

Study Arms (1)

EEG neurofeedback

EXPERIMENTAL

All participants will receive 20 sessions of traditional occupational therapy services while receiving EEG neurofeedback.

Device: Zengar Electroencephalogram (EEG) Neurofeedback device

Interventions

Electroencephalogram (EEG) Neurofeedback is a noninvasive way to allow the central nervous system to self regulate and calm the brain enough to allow the frontal cortex to function in an ideal state, which is the part of the brain that controls important functions including behavior, problem solving, memory, language, emotions, and judgment. EEG Neurofeedback is performed via a musical medley that lasts for about 34 minutes, with baseline numbers taken at the beginning and after the music finishes. During this time, the participant will wear headphones, sensory clips on the ears (3 total), and two sensors on their head while receiving traditional occupational therapy services.

EEG neurofeedback

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • school aged children: ages 6 to 18 years old.
  • score of 4 out of 9 on the BRIEF-2 assessment, indicating a potentially clinically elevated or clinically elevated need for therapeutic intervention

You may not qualify if:

  • score of 3 or less of the 9 categories on the BRIEF
  • ratings that are equal to or higher than 7 on the inconsistency scale (indicating parent/caregiver bias)
  • age requirements not met

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kidabilities Occupational Therapy

Prescott, Arizona, 86305, United States

Location

MeSH Terms

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Interventions

Electroencephalography

Condition Hierarchy (Ancestors)

Leukemia, LymphoidLeukemiaNeoplasms by Histologic TypeNeoplasmsHematologic DiseasesHemic and Lymphatic DiseasesLymphoproliferative DisordersLymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, NeurologicalDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosis

Central Study Contacts

Lauren Hall, OTD

CONTACT

Catherine Young, MOT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Co-PI Catherine Young will be completing all evaluations and de-indentification of study participants. I (Lauren Hall) will be working with the de-identified data.
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: One single group of 30 pediatric participants will undergo 20 sessions of traditional occupational therapy services while receiving EEG neurofeedback within each session. Standardized assessment will be administered at the beginning of the session and at the end of 20 sessions to compare differences between executive functioning skills.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor of Occupational Therapy

Study Record Dates

First Submitted

December 12, 2019

First Posted

January 9, 2020

Study Start

January 1, 2020

Primary Completion

December 1, 2020

Study Completion

July 1, 2021

Last Updated

January 9, 2020

Record last verified: 2020-01

Locations